Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: Effects on radiation therapy
- Lingyun Li,
- Amyn Rojiani,
- Dietmar W. Siemann(corresponding author)
- University of Florida,
- University of South Florida
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Purpose: The aim of this study was to evaluate the antitumor efficacy of combretastatin A-4 disodium phosphate (combretastatin prodrug) in the rodent KHT sarcoma model either alone or in combination with radiation therapy. Methods: KHT tumors were grown in C3H/HeJ mice. Combretastatin A-4 prodrug was injected intraperitoneally at doses ranging from 10 to 100 mg/kg. Tumors were irradiated in unanesthetized mice using a <sup>137</sup>Cs source. Tumor response to combretastatin A-4 prodrug was assessed by histological evaluations as well as an in vivo to in vitro cell survival assay. Results: Histological evaluation showed morphological damage of tumor cells within a few hours after drug treatment, followed by extensive central necrosis. Administering increasing doses of combretastatin A-4 prodrug to tumor- bearing mice resulted in a dose-dependent increase in cell killing irrespective of whether the tumors were irradiated or not. When combined with radiation, a 100 mg/kg dose of combretastatin A-4 prodrug reduced tumor cell survival 10-500-fold lower than that seen with radiation alone. Further, the shape of the cell survival curve observed following the combination therapy suggested that including combretastatin in the treatment had a major effect on the radiation-resistant hypoxic cell subpopulation associated with this tumor. Conclusion: The present results demonstrated that in the KHT sarcoma, combretastatin A-4 prodrug caused rapid vascular shutdown, a concentration- dependent direct cell killing, and effective enhancement of the antitumor effects of radiation therapy.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 899-903 (5 pages)Journal (Volume, Issue Number)
International Journal of Radiation Oncology Biology Physics (Volume 42, Issue 4)Publication milestones
- Published - 11/01/1998
Publication status
Published - 11/01/1998
ISSN
0360-3016Publication IDs
- Scopus: 0031742231
- PubMed: 9845118
Publication metrics
Metrics
SciVal
FWCI
12.70
SciVal
Author count
3
SciVal
citations
130
SciVal
Paper percentile
96
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
21
Citation count
134
Funding Details
The authors thank Sharon Lepler and David Bloom for providing excellent technical assistance. This work was supported in part by a grant from OXiGENE Inc. and PHS Grant CA 36858.
FundersFunding number
OXiGENE Inc.
-PHS
-NCI
R01CA036858
